# APARNA ORGANICS LIMITED – FDA Inspection, Mar 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/4e97b0f0-df03-4367-8141-692c9941c291
Source feed: FDA_Inspections

> FDA inspection 1086615 of APARNA ORGANICS LIMITED, March 15, 2019. Classification: Official Action Indicated (OAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086615
- Company Name: APARNA ORGANICS LIMITED
- Inspection Date: 2019-03-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1222652 - 2023-09-12](https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/bd155553-3188-4b59-a51e-b84a6ce2ee6b)
- [FDA Inspection 1047293 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/aparna-organics-limited/7b282ee2-96d0-4f52-b260-9211b0fabee2)

## Related Officers

- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/tenzin-jangchup/733eb315-0eeb-40ce-af6d-03b406a9235d)

Company: https://www.keypedia.com/companies/aparna-organics-limited/490be972-8080-4d97-a1f7-a704853a0323

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c